Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04838951
Other study ID # 2021.141
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 19, 2021
Est. completion date December 31, 2022

Study information

Verified date February 2023
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigator's hypothesis is that a CADe system (ENDO-AID) would improve the adenoma detection rate in junior endoscopists.


Description:

Colorectal cancer (CRC) is the most common and second most lethal cancer in Hong Kong with more than 5,600 new cases and 2,300 deaths annually. Colonoscopy with polypectomy has shown to reduce CRC-related mortality by 53%. However, high polyp miss rates were reported to be up to 26% for adenomas and 9% for advanced adenomas in standard colonoscopies. Risk factors included proximal location, serrate or flat lesions, poor bowel preparation and short withdrawal time (<6 minutes). Insufficient trainee experience was also associated with a higher adenoma miss rate. A significant proportion of interval CRC was attributed to the missed lesions during index colonoscopy leading to adverse patient outcomes. As a result, various techniques were developed to improve adenoma detection rate (ADR) during colonoscopies. Techniques including water exchange method, second examination of the right colon (retroflexion or second forward view)and cap/cuff-assisted colonoscopies were proven to increase ADR effectively. However, these techniques were operator-dependent requiring certain level of expertise. Recently, artificial intelligence and computer-aided polyp detection (CADe) systems have developed rapidly around the globe. These systems can provide real-time CADe by flagging the suspected lesions to endoscopists, with the adoption of deep learning or convoluted neural networks. A number of prospective randomized clinical trials reported a significant increase in ADR in CADe group. The number of adenoma detected per colonoscopy was consistently higher among different polyp sizes, location and morphology. The ADR increment was particularly higher for diminutive adenomas smaller than 5mm. Nevertheless, most of the aforementioned studies only involved senior endoscopists for the procedures. Theoretically, the senior endoscopists were more skillful to expose colonic mucosa and more experienced to distinguish the false positive computer signals, leading to an enhanced performance of CADe in real-time colonoscopies. The effect of CADe on inexperienced junior endoscopists performing colonoscopies remains largely unknown. In this single-blind randomized study, the investigators aim to evaluate the effect of a new CADe system (ENDO-AID) on adenoma detection and quality improvement in junior endoscopists.


Recruitment information / eligibility

Status Completed
Enrollment 856
Est. completion date December 31, 2022
Est. primary completion date July 22, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Aged 18 years old or above; 2. They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or gastrointestinal bleeding; 3. Written informed consent obtained. Exclusion Criteria: 1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation) 2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, significant bleeding tendency, uninterrupted anticoagulation or dual antiplatelets) 3. Scheduled staged procedure for polypectomy or biopsy 4. Previous colonic resection 5. Personal history of colorectal cancer 6. Personal history of polyposis syndrome 7. Personal history of inflammatory bowel disease 8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above) 9. Pregnancy 10. Unable to obtain informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ENDO-AID CADe
ENDO-AID CADe will be used during the withdrawal process of the colonoscopy.

Locations

Country Name City State
Hong Kong Prince of Wales Hospital Shatin New Territories

Sponsors (1)

Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary ADR adenoma detection rate During the colonoscopy
Secondary ADR for adenomas of different sizes <5mm, 5-10mm, >10mm During the colonoscopy
Secondary ADR for adenomas of different colonic segments caecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, rectum During the colonoscopy
Secondary Mean number of adenomas per colonoscopy Mean number of adenomas per colonoscopy During the colonoscopy
Secondary Advanced adenoma detection rate Advanced adenoma detection rate During the colonoscopy
Secondary Sessile serrate lesion (SSL) detection rate Sessile serrate lesion (SSL) detection rate During the colonoscopy
Secondary Polyp detection rate Polyp detection rate During the colonoscopy
Secondary Non-neoplastic resection rate defined as absence of adenoma or SSL within resected specimen During the colonoscopy
Secondary Missed polyp rate defined as a polyp which the junior endoscopist fails to recognize and withdraws the endoscope to next colonic segment, but detected by the supervisor During the colonoscopy
Secondary False positive rate defined as computer artifacts due to colonic mucosal wall or bowel content lasting for >2 seconds During the colonoscopy
Secondary Cecal intubation time Cecal intubation time During the colonoscopy
Secondary Withdrawal time excluding interventions During the colonoscopy
Secondary Total procedural time Total procedural time During the colonoscopy
Secondary Percentage of change in ADR in relation to the personal experience in colonoscopy Percentage of change in ADR in relation to the personal experience in colonoscopy based on number of procedures performed <200 vs 200-500 During the colonoscopy
See also
  Status Clinical Trial Phase
Completed NCT03637712 - Deep-Learning for Automatic Polyp Detection During Colonoscopy N/A
Recruiting NCT04894708 - Study on the Use of Artificial Intelligence (Fujifilm) for Polyp Detection in Colonoscopy N/A
Completed NCT04640792 - A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy N/A
Recruiting NCT04422548 - Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy? N/A
Not yet recruiting NCT06333392 - Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial N/A
Completed NCT03458390 - Use of a Colon Irrigation Device as a Preparation for a Colon Visualization Procedure N/A
Completed NCT02194959 - Peer Patient Navigation for Colon Cancer Screening N/A
Terminated NCT01782014 - Comparison of Adenoma Detection Rate Among Water, Carbon Dioxide and Air Methods of Minimal Sedation Colonoscopy Phase 3
Completed NCT01838408 - Evaluation of Proposed EZ2go Complete Bowel Cleansing System N/A